TORONTO, ONTARIO–(Marketwired – Sept. 19, 2016) – Nutritional High International Inc. (the “Company” or “Nutritional High“) (CSE:EAT)(OTCQB:SPLIF)(FRANKFURT:2NU), is pleased to announce that The Clinic Effingham (“TCE“) will hold its grand opening to patients in the State of Illinois on Tuesday, September 20th, 2016 at 10AM.
Nutritional High CEO Jim Frazier provided the following comments: “We are excited to announce an opening of The Clinic Effingham and are looking forward to serving the patients of the State of Illinois to assist them in treating their qualifying conditions. We would like to thank our staff, partners, local and state regulatory authorities and the community for all the support.”
TCE staff have been following up with patients who had expressed interest during the TCE open house held on August 15, 2016, and the patient education seminars held over the last few weeks. The dispensary menu and hours, as well as the information for patients who would like to register with our dispensary, are available on http://clinicillinois.com/.
To accommodate additional interest from prospective patients, TCE will be holding three additional patient information seminars on: Monday, September 19th at 10:00 am, Monday, September 26th at 10:00 am, and Tuesday, September 27th at 6:00 pm. If you wish to attend and your schedule conflicts with these dates, please feel free to contact TCE for an appointment.
TCE if fully stocked with a range of products and is ready to commence sales. Pictures of TCE and its product counter displays can be seen on the Company’s social media feeds.
Nutritional High also wishes to correct the figures in its press release date dated September 12, 2016. The number of Units issued in the second tranche was 11,445,959, not 5,722,980, for aggregate gross proceeds of $400,609. The total number of Units issued pursuant to this Offering, together with the first tranche as announced on August 31, 2016, was 22,878,538, not 11,439,270 for aggregate gross proceeds of $800,749. We apologize for any confusion this might have caused.
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries, including edibles and oil extracts for nutritional, medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
About The Clinic Effingham
The Clinic Effingham represents a partnership between Ataraxia, GTI and Nutritional High. This partnership includes leading Illinois dispensary and cultivation operators with a track record of successfully serving patients and positively impacting the communities in which they operate.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable real estate and raising sufficient financing to complete the Company’s business strategy. There is no certainty that any of these events will occur. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act“), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.